BioAge Labs, Inc. (BIOA)

5.935 -0.40 (-6.39%) USD  |  NASDAQ  |  Oct 12, 10:54
More

BioAge Labs Cash and Short Term Investments (Quarterly) : 318.74M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 318.74M
March 31, 2026 383.19M
December 31, 2025 281.10M
September 30, 2025 285.78M
June 30, 2025 297.30M
March 31, 2025 320.52M
Date Value
December 31, 2024 354.35M
September 30, 2024 334.47M
June 30, 2024 159.08M
March 31, 2024 177.30M
December 31, 2023 24.96M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Neumora Therapeutics, Inc. 116.83M
Alumis, Inc. 502.29M
ANI Pharmaceuticals, Inc. 375.87M
Corcept Therapeutics, Inc. 308.20M
Veru, Inc. 25.79M